These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34382583)

  • 21. Systematic profiling of a novel prognostic alternative splicing signature in hepatocellular carcinoma.
    Zhang D; Duan Y; Wang Z; Lin J
    Oncol Rep; 2019 Dec; 42(6):2450-2472. PubMed ID: 31578577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma.
    Chang YS; Tu SJ; Chiang HS; Yen JC; Lee YT; Fang HY; Chang JG
    Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33142748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using mRNAsi to identify prognostic-related genes in endometrial carcinoma based on WGCNA.
    Liu J; Wu Z; Sun R; Nie S; Meng H; Zhong Y; Nie X; Cheng W
    Life Sci; 2020 Oct; 258():118231. PubMed ID: 32791150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel prognostic alternative splicing signature in papillary renal cell carcinoma.
    Duan Y; Zhang D
    J Cell Biochem; 2020 Jan; 121(1):672-689. PubMed ID: 31407370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploration of predictive and prognostic alternative splicing signatures in lung adenocarcinoma using machine learning methods.
    Cai Q; He B; Zhang P; Zhao Z; Peng X; Zhang Y; Xie H; Wang X
    J Transl Med; 2020 Dec; 18(1):463. PubMed ID: 33287830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
    Zhang Q; Xia T; Qi C; Du J; Ye C
    BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value and potential function of splicing events in prostate adenocarcinoma.
    Huang ZG; He RQ; Mo ZN
    Int J Oncol; 2018 Dec; 53(6):2473-2487. PubMed ID: 30221674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of RNA Modification-Associated Alternative Splicing Signature as an Independent Factor in Head and Neck Squamous Cell Carcinoma.
    Liu J; Deng W; Xiao Z; Huang X; Lin M; Long Z
    J Immunol Res; 2022; 2022():8976179. PubMed ID: 36157883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma.
    Zhang D; Duan Y; Cun J; Yang Q
    Front Genet; 2019; 10():278. PubMed ID: 30984247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer.
    Yu S; Hu C; Liu L; Cai L; Du X; Yu Q; Lin F; Zhao J; Zhao Y; Zhang C; Liu X; Li W
    J Transl Med; 2020 Jul; 18(1):286. PubMed ID: 32723333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of drug targets and prognosis projection for uterine carcinosarcoma based on alternative splicing events.
    Zhang X; Yin X; Zhang L; Ye Z; Liang G
    Comput Biol Med; 2023 Jan; 152():106346. PubMed ID: 36470146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An integrated autophagy-related gene signature predicts prognosis in human endometrial Cancer.
    Zhang J; Wang Z; Zhao R; An L; Zhou X; Zhao Y; Wang H
    BMC Cancer; 2020 Oct; 20(1):1030. PubMed ID: 33109128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Prognostic Index Based on Alternative Splicing in Papillary Renal Cell Carcinoma.
    Wu Z; Liu J; Sun R; Chen D; Wang K; Cao C; Xu X
    Front Genet; 2019; 10():1333. PubMed ID: 32063918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival-Associated Alternative Messenger RNA Splicing Signatures in Pancreatic Ductal Adenocarcinoma: A Study Based on RNA-Sequencing Data.
    Zhou YJ; Zhu GQ; Zhang QW; Zheng KI; Chen JN; Zhang XT; Wang QW; Li XB
    DNA Cell Biol; 2019 Nov; 38(11):1207-1222. PubMed ID: 31483163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma.
    Wan Q; Sang X; Jin L; Wang Z
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32098099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes.
    Xiong C; Wang G; Bai D
    Bioengineered; 2020 Dec; 11(1):1034-1046. PubMed ID: 32951492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Value and Potential Role of Alternative mRNA Splicing Events in Cervical Cancer.
    Shao XY; Dong J; Zhang H; Wu YS; Zheng L
    Front Genet; 2020; 11():726. PubMed ID: 32793282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of prognostic alternative splicing signatures in uveal melanoma.
    Xie X; Zheng X; Xie T; Cai J; Yao Y
    Int Ophthalmol; 2021 Apr; 41(4):1347-1362. PubMed ID: 33479809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of survival-associated alternative splicing events and signatures in adrenocortical carcinoma based on TCGA SpliceSeq data.
    Xu N; Ke ZB; Lin XD; Lin F; Chen SH; Wu YP; Chen YH; Wei Y; Zheng QS
    Aging (Albany NY); 2020 Mar; 12(6):4996-5009. PubMed ID: 32217810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer.
    Chen P; He J; Ye H; Jiang S; Li Y; Li X; Wan J
    Front Genet; 2020; 11():456. PubMed ID: 32547595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.